Bone remodeling is an active, dynamic and lifelong process, and which involves the http://www.jbc.org/cgi
superfamily that is secreted by osteoblastic lineage cells, has been shown to inhibit osteoclastogenesis (8, 9) and to prevent bone loss in rats following ovariectomy (8) .
Application of estrogen has also been shown to stimulate the production of OPG in estrogen-responsive human osteoblastic cell lines and in normal human osteoblasts (10) .
Flavonoids, a group of naturally occurring compounds that are commonly found in variety of vegetables and herbal medicines, have been extensively reported on their ability to affect bone metabolism, and which could be sold as phytoestrogens in the consumer market.
Daidzein and genistein, are the subclass of isoflavones mainly from soybeans and their derivative foods, have been determined to reduce the occurrence of osteoporosis (11) (12) (13) .
Genistein is also known to possess inhibitory effect on bone resorption (14, 15) . Naringin, a flavonoid that found in citrus fruits has been reported to induce the expression of bone morphogenetic protein-2 via PI3K, Akt, c-Fos/c-jun and AP-1 pathway in osteoblasts (16) . Rutin, a glycoside derivative of flavonoid quercetin, was shown to inhibit the ovariectomy-induced osteopenia in female rats (17) . The hypothesis has been addressed that flavonoids could be bioactive molecules that could counteract the deleterious effects of estrogen deficiency occurring during woman menopause.
Here, flavonoids of different subclasses were first screened on their abilities to induce osteogenesis by measuring the activity of alkaline phosphatase (ALP), an indicative osteoblast differentiation marker, in cultured osteoblasts derived from newborn rat calvaria. (Fig. 2D) . Here, both flavones were compared by their activation effects on different reporter constructs (Fig. 3A) . Both flavones induced the estrogenic activity by its activation on pERE-Luc transfected osteoblasts in dose-and time-dependent manners (21): the activation was more robust for baicalein ( Fig. 3B & 3C) . However, the osteogenic activity was only restricted to baicalin, i.e. baicalein did not affect the transcriptional activity of both pWRE-Luc and pRun2x-Luc transfected osteoblasts, even the concentration of the flavone reached 300 μM (Fig. 3B ), or even under 48 hours of treatment (Fig. 3C) . These studies suggested the structure and function relationship of baicalin in having the specificity for the induction of bone differentiation.
EXPERIMENTAL PROCEDURES

Chemicals and flavonoids-
Baicalin-induced osteoblastic differentiation is not mediated by estrogen receptors.
Estrogen is known to play a significant role To test the correlation of estrogenic effect of baicalin and its ability in stimulating osteoblastic differentiation, the cultured osteoblasts were pre-treated with specific ER antagonists before the application of baicalin.
As showed in After 10 min of the treatment, LiCl was able to induce GSK3β phosphorylation in a transient manner (Fig. 5B) . Similarly, baicalin was able transiently to induce the phosphorylation of GSK3β: the maximum induction was ~6 folds, as compared to the buffer-treated control (Fig. 5B, lower panel) . In order to confirm the specificity of baicalin in osteoblasts, the cultures were pre-treated with DKK-1 for one hour before the application of LiCl, or Wnt3a, or baicalin.
The phospho-GSK3β, induced by Wnt3a or baicalin, were markedly inhibited after the pre-treatment of DKK-1 (Fig. 6A) , indicating that baicalin could act on the Wnt-receptor, similar to that of Wnt3a. In contrast, the LiCl-induced phospho-GSK3β could not be abolished by the pre-treatment of DKK-1.
In addition, the activating effect of baicalin on TCF/LEF-dependent gene transcription was tested by a luciferase reporter pWRE-Luc that contained the binding sites for β-catenin-TCF complex (see Fig. 3A ).
The application of baicalin increased pWRE-Luc activity in a dose-dependent manner ( Fig. 6B) : the saturation was reached at ~90 μM of baicalin. Moreover, the baicalin-induced pWRE-Luc activity in the DNA transfected osteoblasts was markedly inhibited by the pre-treatment of DKK-1 in the cultures (Fig. 6B) . ( Fig. 7A & B) . This specific blockage further confirmed the baicalin-activated Wnt/β-catenin signaling was via the receptors.
Baicalin-induced osteoblastic proteins via the
The expression of Runx2, a master transcription factor in controlling the osteobast differentiation, in cultured osteoblasts was also determined under the treatment of baicalin. Runx2 protein (at ~57 kDa) (Fig. 8B) . The effect of baicalin on Runx 2 was further tested by using a reporter construct that contained a luciferase enzyme tagged down stream of WRE derived from the mouse Runx2 gene (Fig. 8C upper panel) RANKL, receptor activator for nuclear factor κ B ligand. 
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